Estrogen and Gender Biased Autoimmunity
NCT00519454 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2010-09-08
Summary
This study involves research to investigate how estrogen affects women of childbearing age and its correlation to Systemic Lupus Erythematosus. The findings from this study might help determine how body cells, called T Cells, react to estrogen. The study will seek to determine if cells from women with Lupus, react differently from cells in persons without Lupus. We will attempt to identify genetic factors that determine the effects of estrogen on Lupus cells.
Conditions
Interventions
- OTHER
-
Peripheral lab draws
100ml blood for analysis, taken no more than 4 times in one year.
Sponsors & Collaborators
- collaborator INDUSTRY
-
The Center for Rheumatic Disease, Allergy, & Immunology
lead OTHER
Principal Investigators
-
Nabih I Abdou, MD, PhD · The Center for Rheumatic Disease, Allergy and Immunology
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
NCT00657189 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
NCT01127321 ·Status: TERMINATED ·Phase: PHASE1
-
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients
NCT02321709 ·Status: COMPLETED ·Phase: PHASE1
-
The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE
NCT07012239 ·Status: COMPLETED
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Effect of Hormone Replacement Therapy on Lupus Activity
NCT00392093 ·Status: COMPLETED ·Phase: PHASE4
-
Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus
NCT05791799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
NCT06897930 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
NCT00299819 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
NCT02265744 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
NCT02391259 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
New Signaling Pathway Targeting Systemic Lupus Erythematosus
NCT03984227 ·Status: UNKNOWN
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Safety Study of AMG 557 in Subjects With Lupus Arthritis
NCT01683695 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
NCT02954939 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)
NCT01135459 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
NCT01322308 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
NCT00004663 ·Status: COMPLETED
-
Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
NCT00004795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
NCT00137969 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
NCT00482989 ·Status: COMPLETED ·Phase: PHASE1